Legend Biotech Corp (LEGN) stock
LEGNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$16.11+0.12 (+0.75%)
Close on Nov 17, 2026Market cap $2.98BP/E –Yield –
Legend Biotech operating margin
Operating margin is operating income as a percentage of revenue.
Legend Biotech's operating margin for the twelve months ending Jun 30, 2026 was -4.3%. For fiscal 2025 it was -13.3%, against -49.3% the year before.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -13.3% | +36.1 |
| FY2024 | Dec 31, 2024 | -49.3% | +135.9 |
| FY2023 | Dec 31, 2023 | -185.2% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 14.9% | +23.5 |
| Q1 FY2026 | Mar 31, 2026 | -16.3% | +10.2 |
| Q4 FY2025 | Dec 31, 2025 | -6.4% | +36.1 |
| Q3 FY2025 | Sep 30, 2025 | -16.0% | +28.0 |
| Q2 FY2025 | Jun 30, 2025 | -8.6% | – |
| Q1 FY2025 | Mar 31, 2025 | -26.5% | – |
| Q4 FY2024 | Dec 31, 2024 | -42.5% | – |
| Q3 FY2024 | Sep 30, 2024 | -43.9% | – |
See a number that looks wrong?